Biomarkers in Bladder Cancer Survellance

Keyphrases

• FDA-approved Drugs 100%
• Cystoscopy 100%
• Bladder Cancer 100%
• Clinical Trials 66%
• Non-muscle Invasive Bladder Cancer (NMIBC) 66%
• Protein Biomarkers 66%
• Urinary Biomarkers 66%
• Urine Cytology 66%
• DNA Sequencing 33%
• Molecular Biomarkers 33%
• Meta-analysis 33%
• Background Current 33%
• Low-grade Tumor 33%
• PubMed 33%
• Extracellular Vesicles 33%
• Narrative Review 33%
• Clinical Observational Study 33%
• Cost Reduction 33%
• Low Sensitivity 33%
• Analytical Method 33%
• Clinical Setting 33%
• Exosomal 33%
• Patient Care 33%
• Accuracy Improvement 33%
• Web Search 33%
• Clinical Application 33%
• Bladder Cancer Diagnosis 33%
• Current Guidelines 33%
• Search Engine 33%
• High Specificity 33%
• Epigenetics 33%
• MEDLINE 33%
• Early Development 33%
• Laboratory Techniques 33%
• Benign Condition 33%
• Biomarker Protein 33%
• Google Scholar 33%
• Protein-coding Genes 33%
• Liquid Biomarkers 33%
• Urinary Assay 33%
• RNA-DNA 33%

Medicine and Dentistry

• Bladder Cancer 100%
• Biological Marker 100%
• Cystoscopy 25%
• Cytotechnology 25%
• Clinical Trial 16%
• Prospective Study 16%
• Non Muscle Invasive Bladder Cancer 16%
• Urine Cytology 16%
• Urinary System 16%
• False Positive Result 8%
• Observational Study 8%
• DNA RNA Hybridization 8%
• Systematic Review 8%
• Meta-Analysis 8%
• Neoplasm 8%
• Health Care Cost 8%
• Analytic Method 8%
• Sensitivity and Specificity 8%
• Patient Care 8%